GlassScriptPhysician profile
Nathan S Alexander
NPI 1902009996
$1,243.09
in general payments reported to CMS, 2019-2025
18 companies · $365 in 2025
The $365 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $49.40 · 2021: $123 · 2022: $185 · 2023: $136 · 2024: $175 · 2025: $365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $675.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Bionics, LLC | $283.55 | 2019-2025 | Hires Ultra Ci Hifocus Ms Electrode |
| Med-El Corporation | $204.98 | 2023-2025 | Mi1250 Synchrony 2 Flexsoft, Bci 602 Kit |
| Cochlear Americas | $171.33 | 2019-2025 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Inspire Medical Systems, INC. | $133.24 | 2024-2025 | Inspire |
| Stryker Corporation | $80.66 | 2019-2022 | |
| Genzyme Corporation | $74.15 | 2023-2024 | |
| Intersect Ent, INC. | $44.39 | 2021-2022 | |
| Acclarent, INC | $42.21 | 2021 | |
| Glaxosmithkline, LLC. | $33.81 | 2023 | Nucala |
| Olympus America INC. | $32.40 | 2019-2023 | Olympus |
| Merck Sharp & Dohme LLC | $23.01 | 2023 | Belsomra |
| Optinose US, INC. | $22.21 | 2021 | |
| Ambu INC. | $20.91 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $18.79 | 2024 | Dupixent |
| Boston Scientific Corporation | $17.73 | 2023 | Varithena Administration Pack |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $17.22 | 2021 | |
| Smith+Nephew, INC. | $11.47 | 2020 | |
| Melinta Therapeutics, LLC | $11.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Alexander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.